Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Lenalidomide 5 mg Capsule bulk supplier for pharma manufacturers

Lenalidomide 5 Mg Capsule 5mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 5mg

Reference Brands: Lenalid

Category: Orphan Drugs

Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS). Patients with MDS may have very low red blood cell counts and require blood transfusions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Lenalidomide is an immunomodulatory and antineoplastic agent widely used in the treatment of hematological malignancies. It is marketed globally under the brand name Revlimid, along with several approved generic versions. Lenalidomide is primarily indicated for the treatment of multiple myeloma, where it is used as a first-line therapy in combination with dexamethasone, as well as in relapsed or refractory disease settings.

In addition to multiple myeloma, lenalidomide is used for the treatment of smoldering multiple myeloma, certain indolent non-Hodgkin lymphomas, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, and myelodysplastic syndromes (MDS), particularly those associated with deletion 5q cytogenetic abnormality. The drug works through multiple mechanisms, including immune modulation, inhibition of tumor cell proliferation, and suppression of angiogenesis.

Due to its potent therapeutic effects and safety considerations, lenalidomide is subject to strict prescribing and monitoring requirements in many countries. It remains a cornerstone therapy in modern hematology and oncology treatment protocols worldwide.

Lenalidomide 5 Mg Capsule — third party manufacturing & bulk supply

Lenalidomide 5 Mg Capsule 5mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Lenalidomide 5 Mg Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Lenalidomide 5 Mg Capsule →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Lenalidomide is used in the treatment of certain hematological cancers, primarily multiple myeloma. It is also indicated for myelodysplastic syndromes (MDS) associated with deletion 5q, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma, either alone or in combination with other anticancer agents, depending on the indication and treatment protocol.

Lenalidomide is a synthetic immunomodulatory agent derived from thalidomide. It is chemically manufactured and designed to enhance immune function, inhibit tumor cell proliferation, and suppress angiogenesis.

Lenalidomide is globally marketed under the trade name Revlimid.

The original branded product Revlimid was developed and marketed by Celgene Corporation, which is now a part of Bristol Myers Squibb. Generic versions are manufactured by several approved pharmaceutical companies in different regions.

The complete generic name is lenalidomide.

The brand name of lenalidomide is Lenalid, Revlimid, along with various approved generic brands available in different countries.

Lenalidomide is manufactured in multiple countries including the United States, European Union countries, India, and other regulated pharmaceutical manufacturing regions, depending on the brand and manufacturer.

Related Products

Palovarotene

Strength:
5 mg, 10 mg

Form: Capsules

Reference Brands: Sohonos (USA/EU)

View Details
Pasireotide Diaspartate

Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg

Form: Injection

Reference Brands: Signifor (USA/EU)

View Details
Sepiapterin

Strength:
1000 mg, 250 mg

Form: Tablets / oral powder

Reference Brands: Sephience (USA/EU)

View Details
Glycerol Phenylbutyrate

Strength:
1.1 g/mL

Form: Oral Solution

Reference Brands: Ravicti (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.